The AI Governance Landscape: A Minefield for Regulated Industries
In a world where 47 countries have active AI-specific legislation and over 1,000 policies tracked, regulated industries are facing unprecedented complexity in AI decision-making. For healthcare, insurance, and financial services executives in Canada and the UK, this translates to significant exposure from unexamined AI choices.
The core complaint is fragmentation – no single entity can track the ever-changing landscape alone. Independent judgment fills this gap, providing a critical safeguard against costly failures.
Buying or deploying AI in regulated sectors poses three key risks: capability risk (does the technology do what was claimed), governance risk (can the decision be defended when boards or regulators ask), and liability risk (what is the organisation accountable for when the AI errs). In this case, it’s capability risk that sharpens most – can organisations trust their chosen solutions to deliver on promises?
A prudent response involves three strategic steps: re-evaluate AI vendors based on capabilities, assess governance frameworks, and prepare for potential liabilities. Unfortunately, many struggle with these moves due to vendor information asymmetry and internal teams too close to the decision-making process.
Straven & Co bridges this gap by providing independent AI validation, examining AI decisions against organisations’ operations, people, governance, legal exposure, and vendors’ claims. The company delivers a clear verdict: proceed, proceed with conditions, or do not – a trusted assessment that can save reputations, patient and customer trust, and financial resources.
Straven & Co examines AI decisions before they are acted on: stravenandco.com